specifies that the drugs that cms, hhs would pick drugs that have the highest drug expenditures. the expenditures for medicare. so, that s really the process by which these drugs are selected. then there is a negotiation over the next year, really. over the next month, cms and the manufacturers are gonna mix several months, we ll have a negotiation. and the price will be selected, determined by september of next year. the fall of 2024. this will, like you said, expand year after year. new drugs added to this roster. it s interesting, i have noticed, there hasn t been a ton of republicans talking one way or another about this today. which i thought was kind of interesting. largely silent on this. michael burgess i, saw a member from texas, said cms is holding pharmaceutical companies hostage, jeopardizing future innovative treatments and the
US VP Speaks at Campaign Reception 4 August
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
achieve something for veterans, make the tweak. they want to attack republicans for hating veterans and scoring political points they can keep doing what they re doing. bret: let s talk about this manchin, humans deal you heard the senator on the specifics. what is your take about where the stands and where it s going? i think joe manchin for the life back into the biden demonstration slate of agenda this past week. he is right it closes on the tax loopholes for there s a lot of debate about the text piece of this print does a couple of things he biden administration believes are important but allowing medicare to negotiate drug prices for example, bringing down inflation but here people like larry summers who is not always been a fan of the biden ministration policy saying this bill will actually reduce inflation in the long haul. i think there are a number of priorities with its energy security, springing down inflation, whether it s negotiating prescription drug prices that will h
bill because basically negotiating and working on this has a drug pricing we are able to save costs is fars high cost in pharmaceuticals and bring that down for medicare. let medicare negotiate that was great and i appreciate that. also she s been very adamant about tax increases. we made sure there s no tax increases. loopholes is a different thing. efraim believes we should pay their fair share. she seemed blindsided you didn t bring her in on the decision? i did bring anybody in because i didn t want anyone to be disappointed again. i have gone through eight months smart political thing is do nothing i guess that s what a lot of people do just sit back and do nothing because you can t get criticized for it. i never did quit looking for a better avenue for that solid energy production, reliability and fight inflation for that s what he been trying to do. i did not want to bring anyone into the fold that said this think might fall apart here s a joke going down the road again and
make the tweak. they want to attack republicans for hating veterans and scoring political points they can keep doing what they re doing. bret: let s talk about this manchin, humans deal you heard the senator on the specifics. what is your take about where the stands and where it s going? i think joe manchin for the life back into the biden demonstration slate of agenda this past week. he is right it closes on the tax loopholes for there s a lot of debate about the text piece of this print does a couple of things he biden administration believes are important but allowing medicare to negotiate drug prices for example, bringing down inflation but here people like larry summers who is not always been a fan of the biden ministration policy saying this bill will actually reduce inflation in the long haul. i think there are a number of priorities with its energy security, springing down inflation, whether it s negotiating prescription drug prices that will help average americans, the sebag
vimarsana © 2020. All Rights Reserved.